Lilly weight-loss drug copycats dealt blow
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
Tirzepatide was granted approval from the Medicines and Healthcare products Regulatory Agency last November, while NICE ...
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...
Jelly Roll’s wife Bunnie XO details horrifying experience ‘microdosing’ a weight loss drug - The wife of the country singer ...
Nearly 250,000 people in England could be taking Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro within three years ...